# IL-34 as a Novel Mediator Linking Vitamin D Deficiency with Osteoporosis and Knee Osteoarthritis

**Authors:** Nader Tarabeih, Ali Sleiman, Alexander Kalinkovich, Shai Ashkenazi, Adel Shalata, Gregory Livshits

PMC · DOI: 10.3390/ijms262211090 · International Journal of Molecular Sciences · 2025-11-16

## TL;DR

This study finds that vitamin D deficiency is linked to osteoporosis and knee osteoarthritis through increased IL-34 levels, which are influenced by body fat.

## Contribution

The study identifies IL-34 as a novel mediator connecting vitamin D deficiency with osteoporosis and knee osteoarthritis.

## Key findings

- Vitamin D deficiency is associated with elevated IL-34 levels and increased prevalence of osteoporosis and knee osteoarthritis.
- Body fat mass-to-weight ratio is a significant predictor of vitamin D deficiency status.
- IL-34 levels are strongly linked to both osteoporosis and knee osteoarthritis.

## Abstract

Vitamin D deficiency (VDD) is a widespread human condition closely associated with musculoskeletal disorders, involving alterations in body composition and systemic inflammation. In this cross-sectional study, 1075 adults were classified into a VDD (n = 304) group and a VD sufficient (VDS) group (n = 771). Body composition measurements, including the fat mass-to-weight ratio (FM/WT), were assessed using bioelectrical impedance analysis. Plasma levels of IL-9, IL-34, and MCP-1 were also measured. Data on osteoporosis (OP) and knee osteoarthritis (KOA) were collected. Regression analyses indicated that FM/WT was independently associated with VDD, which in turn was linked to elevated IL-34 levels. Individuals with VDD had a significantly higher prevalence of OP and KOA compared with those with VDS. Structural equation modeling confirmed and quantified these associations, suggesting that FM/WT is a significant predictor of VDD status (β = 0.305, 95% CI: 0.231–0.367). VDD is directly associated with elevated IL-34 levels (β = 0.353, 95% CI: 0.308–0.398), while IL-34 levels, in turn, are a possible cause of KOA (β = 0.573, 95% CI: 0.460–0.687) and OP (β = 0.433, 95% CI: 0.329–0.536). Our data clearly demonstrate existence of a physiological-pathological continuum: obesity-VDD-IL-34 and both OP and KOA.

## Linked entities

- **Proteins:** IL34 (interleukin 34), IL9 (interleukin 9), CCL2 (C-C motif chemokine ligand 2)
- **Diseases:** osteoporosis (MONDO:0005298), vitamin D deficiency (MONDO:0100471)

## Full-text entities

- **Genes:** CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, IL34 (interleukin 34) [NCBI Gene 146433] {aka C16orf77, IL-34}, IL9 (interleukin 9) [NCBI Gene 3578] {aka HP40, IL-9, P40}
- **Diseases:** VDD (MESH:D014808), OP (MESH:D010024), obesity (MESH:D009765), inflammation (MESH:D007249), musculoskeletal disorders (MESH:D009140), KOA (MESH:D020370), WT (MESH:D009396)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12652694/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12652694/full.md

## References

111 references — full list in the complete paper: https://tomesphere.com/paper/PMC12652694/full.md

---
Source: https://tomesphere.com/paper/PMC12652694